Analogues of deamino-ti-carba-oxytocin, containing isoleucine, Ocmethyltyrosine or methionine in position 2, either in the sulfide or sulfoxide form, were prepared and studied pharmacologically. These compounds had considerably lower biological activities than the analogous compounds of the l-carba series. Furthermore, analogues of [l,6-homolanthionine]deamino-oxytocin were prepared with Ocmethyltyrosine or isoleucine in position 2; these compounds had a certain degree of oxytocic activity.
The synthesis and pharmacological properties of analogues of deamino-l-carba--oxytocin (Ia), the tyrosine residue of which had been substituted by O-methyltyrosine,*' phenylalanine or isoleucine, have already been described'. As compared with effectors containing a disulfide bridge'-5, all the analogues with a I-carba bridge had significantly higher activities. Moreover, [2-0-methyltyrosine]deamino--l-carba-oxytocin (Ib), like other oxytocin analogues containing O-methyltyrosine in position 2, had protracted activity in the uterotonic and galactogogic assays in vivo 6, 7 ,Earlier experiments also suggested" that 6-carba analogues might have higher nterotonic activity ill vivo; we therefore decided to prepare analogues derived from deamino-6-carba-oxytocin and modified in position 2. The increase of activity should have been most prononnced in the case of [2-0-methyltyrosine]deamino-6-carba--oxytocin (Ie) and we also expected it to have hormonogen properties.
Several analogues of deamino-oxytocin containing an alifatic amino acid in position 2 have already been prepared. The isoleucine derivative' (Id) had a rather high degree of biological activities, whereas analogues containing leucine? or valine"? had very low activities. An analogue with methionine has not been synthetized so far though the electronic properties of the side chain of methionine would place it somewhere Lebl, Barth,Jost : between an aromatic and alifatic residue. We therefore decided to prepare analogues of deamino-6-carba-oxytocin with isoleucine or methionine in position 2. We assumed that if the effects of the substitution of sulfur by a methylene group and the modification in position 2 on the biological activity were of an additive nature, the uterotonic activity of [2- isoleuciue]deamino-6-carba-oxytocin (Ie) would be remarkably high.
The oxidation of sulfur in the thioether bridge of carba analogues decreased their activities!"; this was most pronounced in the case of l-carba compounds. The oxidation of 6-carba analogues did not influence their activity to such a degree l1 . If we take into account the fact that rapid oxidation of thioether sulfur may occur in the blood stream, i.e. under conditions of assays in vivo, as proved in the case of an ACTH fragment':', it follows that 6-carba-analogues should be more active in assays ill vivo than I-carba-analogues.
The oxytocin analogues, the cyclic part of which was enlarged and contained a disulfide bond, either were not active at all or had minimum activity':'. However, the compound containing a CHz-S-CH z group instead of the disulfide bond was found to be relatively highly potent':', We were therefore interested in investigating how further modifications of its molecule might influence its activity. Again we performed the modifications in position 2, which enabled us to compare the activities of the resulting analogue with those of the l-carba and 6-carba series.
When synthetizing analogues of deamino-e-carba-oxytocin, we started with heptapeptide!" lIa which we acylated with the corresponding active ester, thus obtaining octapeptides Ilbr-Lld. We performed cyclization after the removal of the protecting groups by the active ester method. In every case, the cyclization product was subjected to countercurrent distribution. Regarding the isoleucine (Ie) and O-methyityrosine derivatives (Ic), one of the fractions obtained by this purification procedure contained a compound that, judging by results of thin-layer chromatography, was the main component of the crude reaction mixture after cyclization. The compounds obtained after countercurrent distribution were characterized as sulfoxides l1 . ! 5 (If,Ig) and were transformed into sulfides by reduction with hydrogen bromide and acerone'{'!". (It had been established previously that the methyl group is not split off from O-methyityrosine during reductiou under these conditions.) In the case of the methionine analogue (Ill), countercurrent distribution was performed under mild conditions and the resulting product contained only very small traces of substances with a sulfoxide-positive reaction. On the one hand, these substances could be easily removed by gel filtration, on the other, reduction by hydrogen bromide and acetone transformed them into the required product. By contrast, oxidation with sodium periodate yielded a his-sulfoxide (Ii), the chromatographic properties of which were identical with those of one of the products of oxidation contaminating the final product after countercurrent distribution.
We detected sulfoxides by means of Thompson's test" and infrared spectroscopy. There is practically only one method for the quantitative determination of sulfoxides, namely X-ray photoelectron spectroscopy", which, however, is not currently available. Approximate results can be obtained in the case of amino acid sulfoxides by means of an amino acid analyzer, either from the decreased values for amino acids containing sulfur (after hydrolysis with hydrochloric acid 11 • I S ) , or by determining sulfoxide itself after hydrolysis which does not destroy the sulfoxide grouping (alkaline hydrolysis or hydrolysis with toluenesulfonic acid l s • I " ) , or otherwise by indirect methods/".
When preparing analogues with a larger ring, we started with the heptapeptide '" llla which we acylated with active esters of O-methyltyrosine or isoleucine, thus obtaining octapeptides IlIb and IlIc. Cyclization was performed as mentioned above and the isoleucine analogue Ij was purified by countercurrent distribution and gel filtration. No sulfoxide formation was observed in this case. The aualogue containing O-methyltyrosine (Ik) was purified only by gel filtration.
The formation of sulfoxides during the different procedures apparently depended to a great extent on the structure of the individual compounds. We noticed that the analogues belonging to 6-carba series were more susceptible to sulfur oxidation. Analogous derivatives of the l-carba series (2-phenylalanine, 2-isoleucine), described earlier', did not contain sulfoxide, although they were SUbjected to the same procedures as compound Ie in the course of their synthesis and purification. The amino acid in position 2 was also of some importance; in the presence of O-methyltyrosine, sulfur oxidation occurred to a greater extent than when isoleucine was situated in this position. We also observed a strong tendency to sulfoxide formation in the case of l-carba analogues in which the glutamine residue in position 4 was substituted by an alifatic amino acid:". All these findings show that changes of the primary structure cause alterations of the conformation of the molecule (at least in the region of the disulfide bridge 22 ) , thus exposing one or the other sulfur atom to oxidation.
The products obtained were subjected to the uterotonic assay ill vitro and to the galactogogic assay ill vivo. As can be seen in Table I , the oxidation of thioether sulfur does not significantly influence the biological activity of this type of compound", but the influence on the uterotonic activity is quite the reverse of that on the galactogogic activity. We must stress that the increase of the uterotonic activities of sulfoxides If and Ig is rather surprising; it demonstrates that when the conformation of the molecnle has already been altered, the subsequent oxidation of snlfur can have an unexpected effect on the activity of the analogue. Oxidation resulting in his-sulfoxide li led to an almost complete loss of activity; this could be explained by a tendency of both the sulfoxide groups to form a stable polar arrangement which profouudly disturbed the conformation of the peptide necessary for evoking a biological response.
The expected increase of activities of the analogues prepared, as compared with due to the different methods used for the assay.) The methionine analogue III had the highest uterotonic and at the same time the lowest galactogogic activity of all the thioether 6-carba analogues described in this paper. The activities of the O-methyltyrosine analogue Ie in assays ill vivo'are presented in another paper'. Table I shows that the character of the substitution in position 2 is not as important for uterotonic activity as for galactogogic activity.
The analogues with increased ring size (Ij and II<) had a certain degree of typical oxytocin activities; the uterotonic activity of the isoleucine derivative Ij was comparable with the activity of the analogue Ie of the 6-carba series. The activities of the O-methyltyrosine analogue II< were lower by approximately one order of ten. Nevertheless, the specificity of the galactogogic effect of these two compounds was practically identical, by contrast with the analogues of the l-carba or 6-carba series. Water or acetic acid in elemental analyses were calculated to optimally fit the values determined and were not estimated analytically.
Lebl, Barth, Jost: General Method for Preparing Octapeptides IIb-Ild, II/b, and fIle
To the solution of heptapeptide I/a or IlIa (0'5 msr) in dimethylformamide (20 ml), Neethylpiperidine (pH 8-9; wet pH paper) and the appropriate active ester (0'7 ffiM) were added. The mixture was stirred for 20 h at room temperature, a further part of active ester (0'3-0-7 ffiM) and base (pH 8-9) were added and the mixture was stirred till all the compound with a free amino group disappeared (reaction with ninhydrin). The total reaction time is given in Table II . The reaction mixture was evaporated, the residue triturated with light petroleum, the product was collected and washed with ether, ethyl acetate, water, 3% solution of citric acid, and again with water and ether. Table II gives the analytical values of the products. Samples for elemental analysis were precipitated from dimethylformamide with water. Electrophoretic mobilities were determined after the removal of the amino-protecting group. Amino-acid analyses are given in Table III.
Sulfoxide of !2-0~Methyltyrosineldeamino-6-carba-oxytocin (Ig)
The preparation was carried out under nitrogen. To a solution of protected octapeptide lIb (250 mg) in a mixture of dimethylformamide (S ml) and pyridine (S ml), bis-(p-nitrophenyl) sulfite (O'S g) was added and the solution was stirred at room temperature for 7 h. A further part 'Ofsulfite (O'S g) was added andthe last part (0'4 g) after 16 h. 6 h later the mixture was evaporated and triturated with ether, water. and again with ether. The compound obtained (210 mg) was dissolved in trlfluoroacetic acid (8 ml) and after 70 min the mixture was diluted with toluene (S ml) and evaporated. The evaporation was repeated after the addition of more toluene (5 ml), The compound was triturated with ether. dried and dissolved in dimethylformamide (8 ml Table III. [
2-0-Methyl tyrosine[deamino-fi-carbu-oxytocin (Ie)
A solution of HEr in acetic acid (35%; 0·5 ml) was added to a suspension of sulfoxide fg (10 mg) in acetone (l ml) and after 5 min at room temperature the solution was evaporated. The residue was suspended in acetone and the mixture evaporated again. The remnant was dissolved in methanol (0'4 ml) and 3M acetic acid (2 m!) and the solution was transferred onto a Bie-Gel column. Lyofilization gave 7·1 mg of the compound with negative reaction for sulfoxides; RJI 0'17 (S1), 0'12 (82), 0'20 (83), 0·62 (84).
[a]n -78'3" (c 0'1,1'1 acelic acid). For C 4 , I-I 6 9Nll 0,,8.2 C zH 4 • .°2.1-1 2°( 1126) calculated: 52-25% C. 7'07~/, H,13'68% N; found: 51-88% C, 6'76% 1-1, 13'42% N. For amino-acid analysis see Table III .
The octapeptide lIe (250 mg) was transformed into the active ester in the same way as described for the compound Ilb, The ester was dissolved in dimethylformamide (8 ml), 2'9M-HCI in ether ., 00 '" .... Lebl Table III . 
The preparation of the active ester from octapeptide lId (250 mg) and the cyclization was carried out in the same way as was described for the compound IIb. Table III .
To the solution of compound lit (10 mg) in methanol (40 Ill) and water (0'5 ml), sodium periodate (10 mg} was added and the mixture was set aside at room temperature for 2 h. 3M Acetic acid (2 ml) was then added and the compound was purified by gel-filtration; yield, 8·8 mg of the title compound, with R F 0'02 (SI), 0'00 (S2), 0·02 (S3), 0'37 (S4), which gave a strongly positive reaction for sulfoxides. Table III .
[Z-O-Methyltyrosine, l,6-homolanthionineJdeamino-oxytocin (Ik)
The transformation of octapeptide lIb (80 mg) into the active ester and its cyc1ization was carried out as described for the compound lIb. Purification by gel-filtration afforded 6'8 mg of a sulfoxide-negative compound with R F 0'51 (Sl), 0'37 (S2), 0·51 (S3), 0·66 (S4), containing a very small amount of a ninhydrin-positive compound with lower R F values.
[o:J o _86-6°(c 0'1, 1M acetic acid). ForC4SH69Nll 012.CzH40ZS.HzO (1066) calculated: 52'94% C, 7'09% H, 14'15%N; found: 52'66% C, 6'81% H, 14'64% N. For amino-acid analysis see Table III. [2-Isoleucine,I,6-homolanthionineJdeamino-oxytocin (lj) The preparation of the active ester from octapeptide lIIe (350 mg) and its cyclization was performed as described in the case of peptide Ilc. The purification was by means of countercurrent distribution (100 transfers of the upper phase, K = 2'9); yield 120 mg. Half of the amount of this product was further purified by gel-filtration; 24 mg of the title compound, giving negative reaction for the presence of sulfoxides, was obtained. R p 0·21 (S1), 0'23 (82),0'34 (S3), 0'74 (84); [aJ o -68'8°(c 0'1, 3Macetic acid). For C43H73Nll011S.3·5 HzO (1015) calculated: 50'87% C, 7'94% H, 15'17% N; found: 50'74% C, 7'58% H, 15'04% N. For amino-acid analysis see Table III .
Pharmacological Methods
The uterotonic assay was carried out on uterine strips of adult Wistar strain rats, under the influence of oestrogens. The strips were placed into medium z3 which was bubbled through with 95% 0z -5% CO 2 at 30°C. Oxytocin was used as a standard. For the determination of the milk--ejecting activity, lactating female rats (5-14 days after delivery) of the same strain were used. The assay was carried out as described in ref. 
